{
  "KRAS G12C": {
    "disease": [
      "NSCLC",
      "Colorectal Cancer"
    ],
    "approved_drugs": [
      "Sotorasib (Lumakras)",
      "Adagrasib (Krazati)"
    ],
    "related_pathways": "MAPK Signaling",
    "clinical_relevance": "High-Value Target in US Precision Oncology"
  },
  "EGFR Exon 19 del": {
    "disease": [
      "NSCLC"
    ],
    "approved_drugs": [
      "Osimertinib",
      "Gefitinib"
    ],
    "related_pathways": "ErbB Signaling",
    "clinical_relevance": "Standard of Care for Targeted Therapy"
  },
  "HER2 Positive": {
    "disease": [
      "Breast Cancer",
      "Gastric Cancer"
    ],
    "approved_drugs": [
      "Trastuzumab",
      "T-DXd (Enhertu)"
    ],
    "related_pathways": "RTK Signaling",
    "clinical_relevance": "Gold Standard for Antibody-Drug Conjugates (ADC)"
  }
}